Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alkynyl Compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112679290B reveals a cost-effective nickel-catalyzed asymmetric hydroalkynylation for AMG 837 intermediates, offering superior enantioselectivity and mild conditions.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.